Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $151.7400 (1.05%) ($150.9800 - $154.5350) on Mon. Nov. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.61% (three month average) | RSI | 53 | Latest Price | $151.7400(1.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.5% a day on average for past five trading days. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(15%) XBI(14%) DIA(13%) SPLV(12%) XLP(12%) | Factors Impacting ABBV price | ABBV will decline at least -0.805% in a week (0% probabilities). VIXM(-11%) UUP(-8%) JETS(-4%) TBT(-3%) IWN(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.805% (StdDev 1.61%) | Hourly BBV | 1.2 () | Intraday Trend | 0.5% | | | |
|
5 Day Moving Average | $149.55(1.46%) | 10 Day Moving Average | $147.83(2.64%) | 20 Day Moving Average | $147.83(2.64%) | To recent high | -1.1% | To recent low | 13.1% | Market Cap | $267.712b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |